Phase II Study of Everolimus Beyond Progression

NCT02269670 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow to accrual

Conditions

Estrogen Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Progesterone Receptor-positive Breast Cancer
Recurrent Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: everolimus
DRUG: anastrozole
DRUG: letrozole
DRUG: tamoxifen citrate
DRUG: fulvestrant
DRUG: megestrol acetate

Sponsor

Emory University

Collaborators

[object Object]